Palo Alto, CA, United States of America

Anne-Marie Duliege

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Anne-Marie Duliege

Introduction

Anne-Marie Duliege is a prominent inventor based in Palo Alto, California. She has made significant contributions to the field of biotechnology, particularly in the development of peptide compounds that target the erythropoietin receptor.

Latest Patents

Duliege holds four patents, with her latest inventions focusing on erythropoietin receptor peptide formulations and their therapeutic uses. These peptide compounds act as agonists of the erythropoietin receptor (EPO-R) and are designed to treat disorders related to insufficient or defective red blood cell production. The patents also include pharmaceutical compositions that incorporate these peptide compounds along with recommended dosages.

Career Highlights

Anne-Marie Duliege is associated with Affymax, Inc., where she has been instrumental in advancing research and development in her field. Her work has been pivotal in creating innovative solutions for medical challenges.

Collaborations

Duliege has collaborated with notable colleagues, including Richard Stead and Kerstin Leuther, to further enhance her research and development efforts.

Conclusion

Anne-Marie Duliege's contributions to biotechnology through her innovative patents and collaborations highlight her role as a leading inventor in her field. Her work continues to impact the treatment of blood-related disorders significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…